![Companion Diagnostics (CDx)—A Central Laboratory Perspective](https://www.q2labsolutions.com/hs-fs/hubfs/Vitamin%20C%20pills.jpeg?width=240&height=240&name=Vitamin%20C%20pills.jpeg)
In the June issue of Inside Precision Medicine, Alan Wookey, Vice President Companion Diagnostics and Q2 Solutions’ scientific advisor, explores the evolution of companion diagnostics (CDx) since the...
![Seven Core Pieces of the Puzzle: What To Consider When Selecting an Analytical Lab](https://www.q2labsolutions.com/hs-fs/hubfs/in-page-images/science1.jpg?width=240&height=240&name=science1.jpg)
In the June issue of Contract Pharma, Q2 Solution's Chief Scientific Officer Patrice Hugo discusses the breadth of new tech-enabled analytical laboratory techniques that are making an impact in...
![Quality FFPE analysis at single cell resolution: elevating single cell RNA sequencing innovation to the next level for optimized drug discovery and development](https://www.q2labsolutions.com/hs-fs/hubfs/Imported%20sitepage%20images/cagt-leftrail-cta-bg2.jpg?width=240&height=240&name=cagt-leftrail-cta-bg2.jpg)
Authors: Joseph Modarelli, Adam Black and Douglas Wilson
![Three key decisions cell and gene therapy trial sponsors need to make early into drug development](https://www.q2labsolutions.com/hs-fs/hubfs/Imported%20sitepage%20images/cagt-leftrail-cta-bg2.jpg?width=240&height=240&name=cagt-leftrail-cta-bg2.jpg)
In the rapidly growing and innovative therapeutic area, how do clinical trial sponsors effectively navigate the multitude of unique intricacies involved in cell and gene therapy development? In a...
![Advances in Genomic Lab Services Drive Patient-Centered Clinical Trials](https://www.q2labsolutions.com/hs-fs/hubfs/in-page-images/david-lotto-phd.jpg?width=240&height=240&name=david-lotto-phd.jpg)
As pharmaceutical and biotech companies understand the value of cellular-level insights to further personalize patient care, advancements in genomic laboratory capabilities are growing in interest. ...
![Cell therapy: devising a full clinical development plan](https://www.q2labsolutions.com/hs-fs/hubfs/in-page-images/cell-therapy.jpg?width=240&height=240&name=cell-therapy.jpg)
Laboratory assessments — from preclinical research through post-marketing surveillance — determine whether a cell-based therapy for cancer succeeds or fails.Showcasing our IQVIA Connected...
![Improving Pediatric R&D Success: Integrating the Younger Patient and Caregiver’s Perspective into Trial Design](https://www.q2labsolutions.com/hs-fs/hubfs/Abstract%20metal%20vintage%20molecules%20medical%20background.jpeg?width=240&height=240&name=Abstract%20metal%20vintage%20molecules%20medical%20background.jpeg)
Given the multitude of nuances to consider when conducting a pediatric trail, it is vital that sponsor form a comprehensive strategy early in the trail design. Q2 Solutions' Charlie Fix along with...
![Polyclonal lymphoid expansion drives paraneoplastic autoimmunity in neuroblastoma](https://www.q2labsolutions.com/hs-fs/hubfs/Abstract%20molecules%20medical%20background.jpeg?width=240&height=240&name=Abstract%20molecules%20medical%20background.jpeg)
Cell Reports article, with contributions from Martin Buchkovich, Q2 Solutions Genomics Highlights
![Building a Greener Lab](https://www.q2labsolutions.com/hs-fs/hubfs/Portraits/Karen%20Tait.jpg?width=240&height=240&name=Karen%20Tait.jpg)
Why a roadmap towards more sustainable science is essential to improve the environmental impact of pathology labs everywhere
![Benefits of Digital Pathology for Clinical Trial Sponsors and Pathology Teams](https://www.q2labsolutions.com/hs-fs/hubfs/Background%20high%20tech%20image%20of%20dna%20molecule-1.jpeg?width=240&height=240&name=Background%20high%20tech%20image%20of%20dna%20molecule-1.jpeg)
Can advances in tech-enabled solutions and workflows optimize diagnostic analysis while reducing the burden on pathologists?